| [1] |
Obara T, Fujimoto Y.
Diagnosis and treatment of patients with parathyroid carcinoma: an update and review[J]. World J SurgWorld J Surg, 1991, 15(6): 738-744.
doi: 10.1007/BF01665308 |
| [2] |
Sadler C, Gow KW, Beierle EA, et al.
Parathyroid carcinoma in more than 1, 000 patients : a population-level analysis[J]. SurgerySurgery, 2014, 156(6): 1622-1630.
doi: 10.1016/j.surg.2014.08.069 |
| [3] |
Cetani F, Pardi E, Marcocci C, et al.
Parathyroid Carcinoma[J]. Front Horm ResFront Horm Res, 2019, 51(3): 63-76.
doi: 10.1159/000491039 |
| [4] |
Obara T, Okamoto T, Kanbe M, et al.
Functioning parathyroid carcinoma: clinicopathologic features and rational treatment[J]. Semin Surg OncolSemin Surg Oncol, 1997, 13(2): 134-141.
doi: 10.1002/(sici)1098-2388(199703/04)13:2<134::aid-ssu9>3.0.co;2-a |
| [5] |
周建平, 田雨霖.
中国人原发性甲状旁腺功能亢进10年文献回顾(1995~2004年)[J]. 中国普通外科杂志中国普通外科杂志, 2007, 16(1): 78-80.
doi: 10.3969/j.issn.1005-6947.2007.01.024 Zhou JP, Tian YL. A 10-year literature review of Chinese primary hyperparathyroidism (1995~2004)[J]. Chin J Gen SurgChin J Gen Surg, 2007, 16(1): 78-80. doi: 10.3969/j.issn.1005-6947.2007.01.024 |
| [6] |
Di Meo G, Sgaramella LI, Ferraro V, et al.
Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review[J]. Clin Exp MedClin Exp Med, 2018, 18(4): 585-593.
doi: 10.1007/s10238-018-0512-7 |
| [7] |
Rodrigo JP, Hernandez-Prera JC, Randolph GW, et al.
Parathyroid cancer: an update[J]. Cancer Treat RevCancer Treat Rev, 2020, 86: 102012-.
doi: 10.1016/j.ctrv.2020.102012 |
| [8] |
Insogna KL.
Primary hyperparathyroidism[J]. N Engl J MedN Engl J Med, 2018, 379(11): 1050-1059.
doi: 10.1056/NEJMcp1714213 |
| [9] |
Duan K, Mete Ö.
Parathyroid carcinoma: diagnosis and clinical implication[J]. Turk Patoloji DergTurk Patoloji Derg, 2015, 31(Suppl 1): S80-97.
doi: 10.5146/tipath.2015.01316 |
| [10] |
Christakis I, Bussaidy N, Clarke C, et al.
Differrentiating atypical parathyroid neoplasm from prathyroid cancer[J]. Ann Surg OncolAnn Surg Oncol, 2016, 23(9): 2889-2897.
doi: 10.1245/s10434-016-5248-6 |
| [11] |
Cetani F, Frustaci G, Torregrossa L, et al. A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule[J/OL]. World J Surg Oncol, 2015, 13: 270[2019-06-10]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563849/pdf/12957_2015_Article_672.pdf. DOI: 10.1186/s12957-015-0672-9. |
| [12] |
Schaapveld M, Jorna FH, Aben KK, et al.
Incidence and prognosis of parathyroid gland carcinoma: a population-based study in The Netherlands estimating the preoperative diagnosis[J]. Am J SurgAm J Surg, 2011, 202(5): 590-597.
doi: 10.1016/j.amjsurg.2010.09.025 |
| [13] |
Dy BM, Richards ML, Vazquez BJ, et al.
Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not?[J]. Ann Surg OncolAnn Surg Oncol, 2012, 19(7): 2272-2278.
doi: 10.1245/s10434-012-2325-3 |
| [14] |
Wu S, Hwang SS, Haigh PI.
Influence of a negative sestamibi scan on the decision for parathyroid operation by the endocrinologist and surgeon[J]. SurgerySurgery, 2017, 161(1): 35-43.
doi: 10.1016/j.surg.2016.05.048 |
| [15] |
Kao A, Shiau YC, Tsai SC, et al.
Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression[J]. Eur J Nucl Med Mol ImagingEur J Nucl Med Mol Imaging, 2002, 29(8): 1012-1015.
doi: 10.1007/s00259-002-0817-2 |
| [16] |
Allen ME, Semrad A, Yang AD, et al.
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?[J]. Rare TumorsRare Tumors, 2013, 5(1): e12-.
doi: 10.4081/rt.2013.e12 |